PTPamela A. Tamez

Pamela A. Tamez

*This is an algorithmically generated author record based on publicly available information.

Pamela A. Tamez has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • John M. Pezzuto

    Schools of Pharmacy, Nursing, and Health Sciences, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 7907-2091, United States

    8 shared publications
  • Ghee Teng Tan

    Program for Collaborative Research in the Pharmaceutical Sciences, M/C 781, Department of Medical Chemistry and Pharmacognosy, College of Pharmacy, The University of Illinois at Chicago, 833 S. Wood Street, Chicago, IL 60612, United States

    6 shared publications
  • Hong-Jie Zhang

    School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China

    6 shared publications
  • D. Doel Soejarto

    Program for Collaborative Research in the Pharmaceutical Sciences, M/C 781, Department of Medical Chemistry and Pharmacognosy, College of Pharmacy, The University of Illinois at Chicago, 833 S. Wood Street, Chicago, IL 60612, United States

    5 shared publications
  • Nguyen Van Hung

    5 shared publications
  • Nguyen Manh Cuong

    4 shared publications

Latest Publications

  • Defining the role of individuals prepared as a doctor of nurse practice in symptoms science research

    by Letitia Y. Graves, Pamela Tamez, Gwenyth R. Wallen, Leorey N. Saligan


  • Open Access

    Genomic Expression Analyses Reveal Lysosomal, Innate Immunity Proteins, as Disease Correlates in Murine Models of a Lysosomal Storage Disorder

    by Suhail Alam, Michelle Getz, Innocent Safeukui, Sue Yi, Pamela Tamez, Jenny Shin, Peter Velázquez, Kasturi Haldar

    Niemann-Pick Type C (NPC) disease is a rare, genetic, lysosomal disorder with progressive neurodegeneration. Poor understanding of the pathophysiology and a lack of blood-based diagnostic markers are major hurdles in the treatment and management of NPC and several additional, neurological lysosomal disorders. To identify disease severity correlates, we undertook whole genome expression profiling of sentinel organs, brain, liver, and spleen of Balb/c Npc1−/− mice relative to Npc1+/− at an asymptomatic stage, as well as early- and late-symptomatic stages. Unexpectedly, we found prominent up regulation of innate immunity genes with age-dependent change in their expression, in all three organs. We shortlisted a set of 12 secretory genes whose expression steadily increased with age in both brain and liver, as potential plasma correlates of neurological and/or liver disease. Ten were innate immune genes with eight ascribed to lysosomes. Several are known to be elevated in diseased organs of murine models of other lysosomal diseases including Gaucher’s disease, Sandhoff disease and MPSIIIB. We validated the top candidate lysozyme, in the plasma of Npc1−/− as well as Balb/c Npc1nmf164 mice (bearing a point mutation closer to human disease mutants) and show its reduction in response to an emerging therapeutic. We further established elevation of innate immunity in Npc1−/− mice through multiple functional assays including inhibition of bacterial infection as well as cellular analysis and immunohistochemistry. These data revealed neutrophil elevation in the Npc1−/− spleen and liver (where large foci were detected proximal to damaged tissue). Together our results yield a set of lysosomal, secretory innate immunity genes that have potential to be developed as pan or specific plasma markers for neurological diseases associated with lysosomal storage and where diagnosis is a major problem. Further, the accumulation of neutrophils in diseased organs (hitherto not associated with NPC) suggests their role in pathophysiology and disease exacerbation.


  • Open Access

    P. falciparum Modulates Erythroblast Cell Gene Expression in Signaling and Erythrocyte Production Pathways

    by Pamela A. Tamez, Hui Liu, Amittha Wickrema, Kasturi Haldar

    Global, genomic responses of erythrocytes to infectious agents have been difficult to measure because these cells are e-nucleated. We have previously demonstrated that in vitro matured, nucleated erythroblast cells at the orthochromatic stage can be efficiently infected by the human malaria parasite Plasmodium falciparum. We now show that infection of orthochromatic cells induces change in 609 host genes. 592 of these transcripts are up-regulated and associated with metabolic and chaperone pathways unique to P. falciparum infection, as well as a wide range of signaling pathways that are also induced in related apicomplexan infections of mouse hepatocytes or human fibroblast cells. Our data additionally show that polychromatophilic cells, which precede the orthochromatic stage and are not infected when co-cultured with P. falciparum, up-regulate a small set of genes, at least two of which are associated with pathways of hematopoiesis and/or erythroid cell development. These data support the idea that P. falciparum affects erythropoiesis at multiple stages during erythroblast differentiation. Further P. falciparum may modulate gene expression in bystander erythroblasts and thus influence pathways of erythrocyte development. This study provides a benchmark of the host erythroblast cell response to infection by P. falciparum.


  • The host targeting motif in exported Plasmodium proteins is cleaved in the parasite endoplasmic reticulum

    by Andrew R. Osborne, Kaye D. Speicher, Pamela A. Tamez, Souvik Bhattacharjee, David W. Speicher, Kasturi Haldar


  • Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection

    by Pamela A. Tamez, Hui Liu, Sebastian Fernandez-Pol, Kasturi Haldar, Amittha Wickrema

    Malaria parasites are known to invade and develop in erythrocytes and reticulocytes, but little is known about their infection of nucleated erythroid precursors. We used an in vitro cell system that progressed through basophilic, polychromatic, orthochromatic, and reticulocyte stages to mature erythrocytes. We show that orthochromatic cells are the earliest stages that may be invaded by Plasmodium falciparum, the causative agent of fatal human malaria. Susceptibility to invasion is distinct from intracellular survival and occurs at a time of extensive erythroid remodeling. Together these data suggest that the potential for complexity of host interactions involved in infection may be vastly greater than hitherto realized.


  • Open Access

    An Erythrocyte Vesicle Protein Exported by the Malaria Parasite Promotes Tubovesicular Lipid Import from the Host Cell Surface

    by Pamela A. Tamez, Souvik Bhattacharjee, Christiaan van Ooij, N. Luisa Hiller, Manuel Llinás, Bharath Balu, John H. Adams, Kasturi Haldar

    Plasmodium falciparum is the protozoan parasite that causes the most virulent of human malarias. The blood stage parasites export several hundred proteins into their host erythrocyte that underlie modifications linked to major pathologies of the disease and parasite survival in the blood. Unfortunately, most are ‘hypothetical’ proteins of unknown function, and those that are essential for parasitization of the erythrocyte cannot be ‘knocked out’. Here, we combined bioinformatics and genome-wide expression analyses with a new series of transgenic and cellular assays to show for the first time in malaria parasites that microarray read out from a chemical perturbation can have predictive value. We thereby identified and characterized an exported P. falciparum protein resident in a new vesicular compartment induced by the parasite in the erythrocyte. This protein, named Erythrocyte Vesicle Protein 1 (EVP1), shows novel dynamics of distribution in the parasite and intraerythrocytic membranes. Evidence is presented that its expression results in a change in TVN-mediated lipid import at the host membrane and that it is required for intracellular parasite growth, but not invasion. This exported protein appears to be needed for the maintenance of an essential tubovesicular nutrient import pathway induced by the pathogen in the host cell. Our approach may be generalized to the analysis of hundreds of ‘hypothetical’ P. falciparum proteins to understand their role in parasite entry and/or growth in erythrocytes as well as phenotypic contributions to either antigen export or tubovesicular import. By functionally validating these unknowns, one may identify new targets in host–microbial interactions for prophylaxis against this major human pathogen. Plasmodium falciparum, the most virulent form of human malaria, causes disease when it invades a red blood cell. It sends proteins beyond its borders into the host, changing the red cell to make it a suitable environment to live in and to interact with the host immune system. Recent findings have predicted that hundreds of parasite proteins are released into the host red cell. However, most of these proteins have no known function. One major challenge is to understand what role these proteins play in parasite growth in order to design drugs or vaccines that block protein function. In this study, we designed a strategy to characterize ‘hypothetical’ proteins and use one as an example to illustrate the principle. We show that this protein resides within a novel compartment within the red cell and changes lipid transport at the host surface to stabilize a major nutrient pathway formed within the human cell. In principle, this strategy is applicable in determining the functions of other parasite genes involved in pathogen–host interactions.


  • Open Access

    Correction: The Malaria Secretome: From Algorithms to Essential Function in Blood Stage Infection

    by Christiaan van Ooij, Pamela Tamez, Souvik Bhattacharjee, N. Luisa Hiller, Travis Harrison, Konstantinos Liolios, Taco Kooij, Jai Ramesar, Bharath Balu, John Adams, et al.


  • Open Access

    The Malaria Secretome: From Algorithms to Essential Function in Blood Stage Infection

    by Christiaan van Ooij, Pamela Tamez, Souvik Bhattacharjee, N. Luisa Hiller, Travis Harrison, Konstantinos Liolios, Taco Kooij, Jai Ramesar, Bharath Balu, John Adams, et al.

    The malaria agent Plasmodium falciparum is predicted to export a “secretome” of several hundred proteins to remodel the host erythrocyte. Prediction of protein export is based on the presence of an ER-type signal sequence and a downstream Host-Targeting (HT) motif (which is similar to, but distinct from, the closely related Plasmodium Export Element [PEXEL]). Previous attempts to determine the entire secretome, using either the HT-motif or the PEXEL, have yielded large sets of proteins, which have not been comprehensively tested. We present here an expanded secretome that is optimized for both P. falciparum signal sequences and the HT-motif. From the most conservative of these three secretome predictions, we identify 11 proteins that are preserved across human- and rodent-infecting Plasmodium species. The conservation of these proteins likely indicates that they perform important functions in the interaction with and remodeling of the host erythrocyte important for all Plasmodium parasites. Using the piggyBac transposition system, we validate their export and find a positive prediction rate of ∼70%. Even for proteins identified by all secretomes, the positive prediction rate is not likely to exceed ∼75%. Attempted deletions of the genes encoding the conserved exported proteins were not successful, but additional functional analyses revealed the first conserved secretome function. This gave new insight into mechanisms for the assembly of the parasite-induced tubovesicular network needed for import of nutrients into the infected erythrocyte. Thus, genomic screens combined with functional assays provide unexpected and fundamental insights into host remodeling by this major human pathogen. The parasite Plasmodium falciparum causes malaria by replicating inside red blood cells of infected individuals. By exporting many different proteins into the host cell, the parasite changes many of its properties. Knowledge of the identity and function of all the exported proteins will both increase our understanding of the modifications required for parasite survival and provide us with targets that can be inhibited to block the growth of the parasites. Several years ago, a motif within the exported proteins was discovered that allowed them to be exported, which was used to predict the total set of proteins exported to the host cell (the secretome). We show here that the earlier studies have either under- or overestimated the total number of proteins exported into the host cell, and derive a more accurate prediction of proteins exported to the host cell. We validate the predictions by making parasites that express a fusion of predicted exported proteins to the Green Fluorescent Protein (which allows the localization of the protein to be determined visually). This revealed a positive prediction rate of ∼70%. In addition, several proteins were identified that are very likely to play an essential role in infection, with at least one involved in the formation of a structure required for nutrient import.


  • Rourinoside and rouremin, antimalarial constituents from Rourea minor

    by Zhen-Dan He, Cui-Ying Ma, Ghee Teng Tan, Kongmany Sydara, Pamela Tamez, Bounhoong Southavong, Somsanith Bouamanivong, D. Doel Soejarto, John M. Pezzuto, Harry H.S. Fong, et al.


  • Antimalarial Constituents fromNauclea orientalis (L.) L.

    by Zhen-Dan He, Cui-Ying Ma, Hong-Jie Zhang, Ghee Teng Tan, Pamela Tamez, Kongmany Sydara, S. Bouamanivong, Bounhoong Southavong, Djaja D. Soejarto, John M. Pezzuto, et al.

    Bioassay-guided fractionation of the antimalarial-active CHCl3 extract of the dried stem of Nauclea orientalis (L.) L. (Rubiaceae) has resulted in the isolation of two novel tetrahydro-β-carboline monoterpene alkaloid glucosides, naucleaorine (=(16α,17β)-3,14:15,20-tetradehydro-16-ethenyl-17-(β-D-glucopyranosyloxy)-19α-methoxyoxayohimban-21-one; 1) and epimethoxynaucleaorine (2), as well as the known compounds, strictosidine lactam (=(15β,16α,17β)-19,20-didehydro-16-ethenyl-17-(β-D-glucopyranosyloxy)oxayohimban-21-one; 3), 3,4,5-trimethoxyphenol (4), 3α-hydroxyurs-12-en-28-oic acid methyl ester (5), 3α,23-dihydroxyurs-12-en-28-oic acid (6), 3α,19α,23-trihydroxyurs-12-en-28-oic acid methyl ester (7), and oleanolic acid (8). Compounds 1, 2, 6, and 8 showed moderate in vitro activities against Plasmodium falciparum. Their structures and configurations were elucidated by spectrocopic methods including 1D- and 2D-NMR analyses.